Logo

KAVL

Kaival Brands Innovations Group, Inc.

KAVL

Kaival Brands Innovations Group, Inc. • NASDAQ
$0.50 ▲ 3.38% (+0.02)
Market Cap $5.82 M
52w High $1.55
52w Low $0.40
Dividend Yield 0%
P/E -0.83
Volume 11.18K
Outstanding Shares 11.54M

Income Statement

Period Revenue Operating Expense Net Income Net Profit Margin Earnings Per Share EBITDA
Q3-2025 $142.425K ▲ $700.944K ▼ $-559.355K ▲ -392.737% ▲ $-0.049 ▲ $-361.917K ▲
Q2-2025 $4.073K ▼ $2.127M ▼ $-1.998M ▲ -49.055K% ▼ $-0.46 ▲ $-1.797M ▲
Q1-2025 $202.603K ▼ $4.279M ▲ $-4.061M ▼ -2.004K% ▼ $-0.95 ▼ $-3.879M ▼
Q4-2024 $734.964K ▲ $538.884K ▼ $-1.487M ▲ -202.323% ▲ $-0.34 ▲ $-1.267M ▼
Q3-2024 $713.814K $1.787M $-1.572M -220.225% $-0.39 $-1.221M

Balance Statement

Period Cash & Short-term Total Assets Total Liabilities Total Equity
Q3-2025 $1.269M ▼ $11.503M ▼ $1.418M ▼ $10.085M ▼
Q2-2025 $1.806M ▼ $12.23M ▼ $1.588M ▲ $10.642M ▼
Q1-2025 $2.428M ▼ $14.071M ▼ $1.434M ▼ $12.637M ▼
Q4-2024 $3.902M ▼ $16.004M ▼ $2.189M ▼ $13.816M ▲
Q3-2024 $4.525M $17.541M $4.006M $13.535M

Cash Flow Statement

Period Net Income Cash From Operations Cash From Investing Cash From Financing Net Change Free Cash Flow
Q3-2025 $-559.355K ▲ $-536.776K ▲ $0 $0 ▲ $-536.776K ▲ $-536.779K ▲
Q2-2025 $-1.998M ▲ $-578.243K ▲ $0 $-43.667K ▲ $-621.91K ▲ $-578.243K ▲
Q1-2025 $-4.061M ▼ $-905.739K ▼ $0 $-568.949K ▼ $-1.475M ▼ $-905.739K ▼
Q4-2024 $-1.487M ▲ $-793.453K ▼ $0 $170.764K ▼ $-622.689K ▼ $-793.453K ▼
Q3-2024 $-1.572M $-594.57K $0 $4.631M $4.037M $-594.57K

Five-Year Company Overview

Income Statement

Income Statement Kaival’s income statement shows a very small business that has struggled to turn its product presence into meaningful profit. Revenue has dropped sharply from earlier years and then flattened at a very low level, suggesting the legacy distribution business is no longer a strong growth driver. Margins are thin, and the company has consistently recorded losses, although per‑share losses have narrowed over time, partly influenced by reverse stock splits. Overall, the current income profile looks fragile and heavily dependent on new strategic moves rather than the existing core operations.

Balance Sheet

Balance Sheet The balance sheet is very light, with a small base of assets and equity and essentially no traditional debt. This means the company is not weighed down by interest burdens, but it also highlights how limited its financial resources are. Cash on hand has been minimal, leaving little internal cushion to absorb setbacks or fund expansion without outside support. In short, the balance sheet is clean but very thin, which makes access to partners, capital markets, and the planned merger especially important.

Cash Flow

Cash Flow Cash flow has hovered around break‑even to slightly negative from operations, with no meaningful spending on long‑term assets. This indicates the business is not burning cash at an extreme rate, but it is also not generating strong, self-funding cash inflows. Free cash flow mirrors this pattern: modest, fragile, and dependent on tight cost control. The company’s ability to invest heavily in growth or R&D from its own cash generation is currently quite limited, so external funding and strategic transactions are key levers.

Competitive Edge

Competitive Edge Historically, Kaival’s edge has come from exclusive distribution rights for Bidi Vapor products and a notable international licensing relationship with a Philip Morris subsidiary. These arrangements have given it product differentiation, a recognized partner, and a wide retail footprint. At the same time, the business has been heavily concentrated in a single product category exposed to intense regulatory scrutiny and shifting consumer behavior. The proposed merger with Delta Corp would fundamentally change this profile, potentially adding diversification, a broader global footprint, and exposure to logistics and fuel supply, but it also introduces execution risk as the combined entity reshapes its identity and value proposition.

Innovation and R&D

Innovation and R&D Kaival has moved to upgrade its innovation profile by acquiring a sizable patent portfolio from GoFire and housing it within Kaival Labs. This collection of inhalation and vaporizer technologies—covering dose control, safety, tracking, and preservation—positions the company to move beyond being only a distributor and into developing or licensing its own technology. There is also potential to extend into adjacent areas like cannabis, CBD, and even pharmaceutical delivery. However, this is still largely an early-stage story: the patents are promising assets, but broad commercialization, licensing deals, and new product launches remain to be proven in practice.

Summary

Overall, Kaival sits at a turning point. The legacy business has produced modest revenue and ongoing losses, with a very small and thinly capitalized balance sheet but no heavy debt load. Cash flows are weak but not severely negative, leaving little room for large independent initiatives. The company’s real potential now lies in two areas: first, the successful completion and integration of its merger with Delta Corp, which could transform it into a more diversified, logistics-focused public company; and second, the effective monetization of its newly acquired patent portfolio through licensing or new products. At this stage, the story is less about current financial strength and more about whether the strategic pivot and innovation assets can be converted into a sustainable, larger-scale business over time amid ongoing regulatory and execution risks.